VARIATIONS IN DISEASE ACTIVITY AND THERAPEUTIC MANAGEMENT OF RHEUMATOID ARTHRITIS IN DIFFERENT INTERNATIONAL REGIONS: A COMPARISON OF DATA FROM THE CORRONA INTERNATIONAL AND CORRONA US REGISTRIES

被引：0

作者：

Pappas, D. A. ^{[1
]}

Lampl, K. ^{[2
]}

Kremer, M. ^{[3
]}

Radominski, S. C. ^{[4
,5
]}

Gal, J. ^{[6
]}

Nyberg, F. ^{[7
]}

Malaviya, A. ^{[8
]}

Whitworth, A. ^{[9
]}

Rillo, O. ^{[10
]}

Gibofsky, A. ^{[11
]}

Popkova, T. ^{[12
]}

Ho, M. ^{[13
]}

Laurindo, I. ^{[14
]}

Reed, G. W. ^{[9
,15
]}

Kerzberg, E. M. ^{[16
]}

Horne, L. ^{[2
]}

Zahora, R. ^{[17
]}

Saunders, K. C. ^{[9
]}

Pons-Estel, B. A. ^{[18
]}

Onofrei, A. U. ^{[15
]}

Greenberg, J. D. ^{[9
,19
]}

机构：

[1] Columbia Univ, New York, NY USA

[2] AstraZeneca, R&D, Wilmington, DE USA

[3] Albany Med Coll, Albany, NY 12208 USA

[4] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil

[5] CETI, Curitiba, Parana, Brazil

[6] Cty Hosp, Kecskemet, Hungary

[7] AstraZeneca, R&D, Molndal, Sweden

[8] ISIC Superspecialty Hosp, New Delhi, India

[9] CORRONA Inc, Southborough, MA USA

[10] Univ Buenos Aires, Hosp E Tornu, Buenos Aires, DF, Argentina

[11] Cornell Univ, Hosp Special Surg, Weill Med Coll, New York, NY 10021 USA

[12] Russian Acad Med Sci, Res Inst Rheum, Moscow, Russia

[13] AstraZeneca, R&D, Macclesfield, Cheshire, England

[14] Univ Sao Paulo, Sao Paulo, Brazil

[15] Univ Massachusetts, Sch Med, Worcester, MA USA

[16] Univ Buenos Aires, Sch Med, JM Ramos Mejia Hosp, Buenos Aires, DF, Argentina

[17] Revmatol Ambulance, Terezin, Czech Republic

[18] Cardiovasc Inst Rosario, Rosario, Santa Fe, Argentina

[19] NYU, Sch Med, New York, NY USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷

关键词：

D O I：

10.1136/annrheumdis-2014-eular.1692

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

FRI0052

引用

页码：400 / 400

页数：1

共 49 条

[21] JUDGING CURRENT DISEASE-ACTIVITY IN RHEUMATOID-ARTHRITIS - AN INTERNATIONAL COMPARISON
KIRWAN, JR
BELLAMY, N
CONDON, H
BUCHANAN, WW
BARNES, CG
JOURNAL OF RHEUMATOLOGY, 1983, 10 (06) : 901 - 905
[22] Decreasing disease activity thresholds for initiating TNF antagonists from 2003 to 2005 among 1790 rheumatoid arthritis (RA) patients from the CORRONA database.
Yazici, Yusuf
Greenberg, Jeffrey
Reed, George
Kishimoto, Mitsumasa
Hinkle, Kim
Abramson, Steven
Kremer, Joel
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S246 - S246
[23] MAPPING HEALTH CARE COSTS TO CLINICAL DISEASE ACTIVITY WHERE COST DATA IS LACKING - A NOVEL APPROACH USING MEDICAL EXPENDITURE PANEL SURVEY DATA WITH THE CORRONA RHEUMATOID ARTHRITIS DISEASE REGISTRY
Ingham, M.
Ghushchyan, V. H.
Reed, G.
Decktor, D.
Bolce, R.
Bolge, S.
Nair, K., V
VALUE IN HEALTH, 2012, 15 (04) : A37 - A37
[24] Disease Characteristics, Quality of Life, and Work Productivity by Enthesitis Site: Real-world Data From the US Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Mease, Philip J.
Liu, Mei
Rebello, Sabrina
Hua, Winnie
McLean, Robert R.
Hur, Peter
Ogdie, Alexis
JOURNAL OF RHEUMATOLOGY, 2021, 48 (03) : 367 - 375
[25] Cardiovascular disease and risk management in patients with diabetes mellitus and rheumatoid arthritis: data from a large international audit
Semb, A. G.
Rollefstad, S.
Ikdahl, E.
Sexton, J.
Kitas, G.
van Riel, P.
Crowson, C.
Graham, I.
Kerola, A. M.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 87 - 87
[26] COMPARISON OF PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA) AMONG DISEASE ACTIVITY CATEGORIES AFTER 6 MONTHS OF TREATMENT WITH A TUMOUR NECROSIS FACTOR INHIBITOR (TNFI): RESULTS FROM THE CORRONA® RA REGISTRY
Kremer, J. M.
Winkler, A.
Anatale-Tardiff, L.
Mclean, R.
Shan, Y.
Moore, P.
Tundia, N.
Suboticki, J.
Tesser, J.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 625 - 625
[27] Disease Characteristics, Quality of Life, and Work Productivity By Enthesitis Sites: Real-World Data from the US Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
Mease, Philip J.
Liu, Mei
Rebello, Sabrina
Hua, Winnie
McLean, Robert R.
Hur, Peter
Ogdie, Alexis
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[28] Older onset rheumatoid arthritis patients receive biologic therapies less frequently than younger patients despite similar disease activity and severity: Analysis from the CORRONA database.
Tuntuncu, ZN
Kavanagh, A
Reed, G
Kremer, J
Abramson, S
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S402 - S402
[29] Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration
Chatzidionysiou, Katerina
Lie, Elisabeth
Nasonov, Evgeny
Lukina, Galina
Hetland, Merete Lund
Tarp, Ulrik
Ancuta, Ioan
Pavelka, Karel
Nordstrom, Dan C.
Gabay, Cem
Canhao, Helene
Tomsic, Matija
van Riel, Piet L. C. M.
Gomez-Reino, Juan
Kvien, Tore K.
van Vollenhoven, Ronald F.
ARTHRITIS RESEARCH & THERAPY, 2016, 18
[30] Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration
Katerina Chatzidionysiou
Elisabeth Lie
Evgeny Nasonov
Galina Lukina
Merete Lund Hetland
Ulrik Tarp
Ioan Ancuta
Karel Pavelka
Dan C. Nordström
Cem Gabay
Helene Canhão
Matija Tomsic
Piet L. C. M. van Riel
Juan Gomez-Reino
Tore K. Kvien
Ronald F. van Vollenhoven
Arthritis Research & Therapy, 18

← 1 2 3 4 5 →